Contents
200 µg of PANC-1 nuclear extract at 7.11 µg/µl.
Background
PANC-1 nuclear extract was prepared from cell cultures of the human epithelioid pancreatic carcinoma PANC-1 nuclear cell line. The PANC-1 cell line was derived from the ductal tissue of a 56 year old Caucasian male patient with carcinoma of the exocrine pancreas. These cells display an epithelial morphology and possess the type B phenotype for glucose-6-phosphate-dehydrogenase (G6PD). PANC-1 cells are an extensively studied model of human ductal pancreatic cancers and are commonly used in research to study tumorigenicity, cytotoxicity and pharmacodynamics in relation to pancreatic cancer.
Application Notes
PANC-1 nuclear extract is specifically recommended for studies related to ductal pancreatic cancer.
This product has been discontinued
Extract Origin
Human pancreas epithelioid carcinoma
Extract Composition
PANC-1 nuclear extract is supplied in Dilution Buffer (20 mM Hepes (pH 7.9), 100 mM KCl, 1 mM MgCl2, 20% glycerol, 0.5 mM PMSF and 0.5 mM DTT).
Quality Control
Extracts have been quality control tested by Western blot and the Electrophoretic Mobility Shift Assay (EMSA).
Storage
To ensure stability, extracts should be stored at -80°C.
We recommend aliquoting the extracts into single-use fractions and then storing them at -80°C. This eliminates repeated freeze/thaw cycles.
Guarantee
This product is guaranteed for 6 months from date of receipt.
This product is for research use only and is not for use in diagnostic procedures.